Literature DB >> 3490963

Calcium-independent and calcium-dependent mechanisms regulate corticotropin-releasing factor-stimulated proopiomelanocortin peptide secretion and messenger ribonucleic acid production.

J R Dave, L E Eiden, D Lozovsky, J A Waschek, R L Eskay.   

Abstract

We have evaluated the role of calcium in basal and secretagogue-stimulated release of beta-endorphin and PRL and the levels of their respective mRNAs in primary cultured rat anterior pituitary cells. Treatment of anterior pituitary cells with the calcium channel blocker methoxyverapamil (D600; 10 microM) or with calcium-free medium for 1 h did not alter the basal release of beta-endorphin and only partially blocked CRF (10 nM)-stimulated beta-endorphin release. In contrast to these effects of D600 or calcium-free medium on corticotrophs, both of these test conditions decreased basal secretion of PRL from lactotrophs by 50-70% and completely blocked forskolin (10 microM)-stimulated PRL secretion. Although omission of calcium from the culture medium caused a 50% decrease in basal levels of both proopiomelanocortin (POMC) and PRL mRNA, treatment of cells with D600 did not significantly alter the basal levels of POMC or PRL mRNA. Treatment of cells with D600 partially blocked CRF-stimulated elevation of POMC mRNA and forskolin-stimulated elevation of PRL mRNA. The calcium agonist barium (1 mM) produced a 2-fold increase in both beta-endorphin and PRL release, which was blocked by D600. Treatment of cells with barium had no effect on POMC mRNA levels, but increased PRL mRNA levels. D600 treatment of cells partially blocked barium-stimulated PRL mRNA levels. These findings demonstrate a calcium-dependent as well as a calcium-independent component of CRF-stimulated beta-endorphin secretion and CRF-stimulated POMC mRNA elevation. In contrast, PRL secretion and biosynthesis appear to be totally calcium-dependent processes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3490963     DOI: 10.1210/endo-120-1-305

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.

Authors:  T Suda; F Tozawa; I Dobashi; N Horiba; N Ohmori; M Yamakado; M Yamada; H Demura
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein.

Authors:  A L Boutillier; C Gaiddon; D Lorang; J L Roberts; J P Loeffler
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

3.  Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.

Authors:  T Suda; F Tozawa; M Yamada; T Ushiyama; N Tomori; T Sumitomo; Y Nakagami; H Demura; K Shizume
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

4.  Lack of stimulatory effect of 1,25(OH)2 vitamin D3 on beta-endorphin and cortisol secretion.

Authors:  I Zofková; R L Kancheva
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.